MENU
+Compare
VPTDF
Stock ticker: OTC
AS OF
Nov 12 closing price
Price
$0.07
Change
-$0.00 (-0.00%)
Capitalization
11.89M

VPTDF stock forecast, quote, news & analysis

VentriPoint Diagnostics Ltd is a medical device company engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease... Show more

VPTDF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for VPTDF with price predictions
Nov 12, 2025

VPTDF sees its Stochastic Oscillator recovers from oversold territory

On October 27, 2025, the Stochastic Oscillator for VPTDF moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 69 instances where the indicator left the oversold zone. In of the 69 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VPTDF advanced for three days, in of 216 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VPTDF moved out of overbought territory on October 14, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on November 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VPTDF as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VPTDF turned negative on October 29, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 55 similar instances when the indicator turned negative. In of the 55 cases the stock turned lower in the days that followed. This puts the odds of success at .

VPTDF moved below its 50-day moving average on October 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VPTDF crossed bearishly below the 50-day moving average on October 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VPTDF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VPTDF broke above its upper Bollinger Band on October 13, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VPTDF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (204.082) is normal, around the industry mean (63.534). P/E Ratio (0.000) is within average values for comparable stocks, (37.086). VPTDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). VPTDF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (120.482) is also within normal values, averaging (79.919).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VPTDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Boston Scientific Corp (NYSE:BSX), Medtronic plc (NYSE:MDT), Edwards Lifesciences Corp (NYSE:EW).

Industry description

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

Market Cap

The average market capitalization across the Medical/Nursing Services Industry is 5.76B. The market cap for tickers in the group ranges from 1.86K to 224B. ABT holds the highest valuation in this group at 224B. The lowest valued company is CSAY at 1.86K.

High and low price notable news

The average weekly price growth across all stocks in the Medical/Nursing Services Industry was 0%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 6%. MOVE experienced the highest price growth at 127%, while MCRXF experienced the biggest fall at -73%.

Volume

The average weekly volume growth across all stocks in the Medical/Nursing Services Industry was -29%. For the same stocks of the Industry, the average monthly volume growth was -4% and the average quarterly volume growth was 4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 75
Price Growth Rating: 61
SMR Rating: 87
Profit Risk Rating: 93
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
VPTDF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
18 Hook Avenue
Phone
+1 519 803-6937
Employees
N/A
Web
https://www.ventripoint.com